Evidence map›Paper›PMID 42818629›Full record

ArticlebioRxiv : the preprint server for biology2026

Powassan Virus NS5 Antagonizes TYK2-Mediated Immune Signaling Pathways.

Mary O'Mara, Melissa Molho, Andrew P Kurland, Zachary Walter, Ségolène Gracias, Vincent Caval, Nolwenn Jouvenet, Jeffrey R Johnson, Holly Ramage

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mary O'MaraDepartment of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, PA.
Melissa MolhoDepartment of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, PA.
Andrew P KurlandMicrobiology Department, Icahn School of Medicine at Mount Sinai, New York City, NY.
Zachary WalterDepartment of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, PA.
Ségolène GraciasViral Adaptation and Spillover Unit, UMR CNRS 3569, Université Paris Cité, Institut Pasteur, Paris, France.
Vincent CavalViral Adaptation and Spillover Unit, UMR CNRS 3569, Université Paris Cité, Institut Pasteur, Paris, France.
Nolwenn JouvenetViral Adaptation and Spillover Unit, UMR CNRS 3569, Université Paris Cité, Institut Pasteur, Paris, France.
Jeffrey R JohnsonMicrobiology Department, Icahn School of Medicine at Mount Sinai, New York City, NY.
Holly RamageDepartment of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, PA.ORCID 0000-0002-0390-6786

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Powassan virus (POWV) is an emerging neurotropic tick-borne flavivirus, yet the mechanisms by which POWV evades host antiviral immunity remain poorly defined. Here, we identify multiple mechanisms of POWV innate immune antagonism with the viral polymerase NS5 protein as a central inhibitor of cytokine signaling. Both POWV lineages potently inhibited type I interferon (IFN) signaling, and NS5 expression suppressed signaling and downstream interferon-stimulated gene expression. Affinity purification-mass spectrometry identified the host kinase TYK2 as a conserved NS5 interactor. POWV NS5 binds the TYK2 kinase domain through a discrete interface within the RNA-dependent RNA polymerase (RdRp) region between catalytic motifs B and C and inhibits TYK2 phosphorylation. Disruption of this interface abrogated TYK2 binding and reduced NS5-mediated IFN antagonism, while revealing additional TYK2-independent mechanisms of immune suppression. POWV NS5 also inhibited TYK2-dependent IFN-λ and IL-12 signaling, demonstrating that its immune antagonism extends beyond Type I IFN. Together, these findings identify TYK2 as a central target of POWV immune evasion and implicate the variable RdRp B-C region as an interface for flavivirus-host interactions. More broadly, our results reveal how POWV can coordinately suppress multiple antiviral cytokine pathways and provide insight into mechanisms that may shape tick-borne flavivirus host adaptation and pathogenesis.

Identifiers

PMID42818629
PMCPMC13622581

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.